The vision of the PSORT consortium is to better understand the determinants of response of psoriasis to biologic therapies. By collaboration with our partners from industry we will develop a  clinical test  to predict response and thereby rationalise and optimise patient care in a cost-effective manner.

About

About PSORT

The programme of research in the Psoriasis Stratification to Optimise Relevant Therapy (PSORT) consortium aims to use existing knowledge about psoriasis, both clinical and scientific

More Information
About

What is Psoriasis?

Psoriasis is an immune condition, which causes symptoms on the skin and sometimes the joints. Psoriasis is a common skin condition affecting up to 3% of the population of the UK & Ireland

More Information
About

Contact Us

Please contact us if you would like further information about PSORT using the form below.

Useful Links

PSORT Partners

Internationally competitive expertise exists across the consortium between investigators and collaborators in all of the scientific disciplines required to successfully deliver the PSORT programme.

We have developed an extensive network of pharmaceutical and diagnostic company partners who bring specific expertise and resources to the programme.